UK markets close in 3 hours 19 minutes

Fresenius Medical Care AG & Co. KGaA (FMCQF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
47.200.00 (0.00%)
At close: 03:47PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 13.83B
Enterprise value 26.63B
Trailing P/E 15.00
Forward P/E 11.01
PEG ratio (5-yr expected) 0.74
Price/sales (ttm)0.73
Price/book (mrq)1.00
Enterprise value/revenue 1.48
Enterprise value/EBITDA 7.71

Trading information

Stock price history

Beta (5Y monthly) 0.94
52-week change 3-42.81%
S&P500 52-week change 3-8.83%
52-week high 383.75
52-week low 346.43
50-day moving average 359.74
200-day moving average 365.13

Share statistics

Avg vol (3-month) 35.87k
Avg vol (10-day) 33.52k
Shares outstanding 5293.03M
Implied shares outstanding 6N/A
Float 8198.65M
% held by insiders 132.20%
% held by institutions 137.38%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.41
Forward annual dividend yield 42.72%
Trailing annual dividend rate 31.35
Trailing annual dividend yield 32.86%
5-year average dividend yield 4N/A
Payout ratio 444.67%
Dividend date 3N/A
Ex-dividend date 412 May 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 4.89%
Operating margin (ttm)9.57%

Management effectiveness

Return on assets (ttm)3.16%
Return on equity (ttm)8.12%

Income statement

Revenue (ttm)17.96B
Revenue per share (ttm)61.29
Quarterly revenue growth (yoy)8.00%
Gross profit (ttm)5.08B
EBITDA 2.59B
Net income avi to common (ttm)877.72M
Diluted EPS (ttm)3.13
Quarterly earnings growth (yoy)-36.80%

Balance sheet

Total cash (mrq)1.17B
Total cash per share (mrq)4
Total debt (mrq)13.34B
Total debt/equity (mrq)91.78
Current ratio (mrq)1.26
Book value per share (mrq)45.17

Cash flow statement

Operating cash flow (ttm)2.44B
Levered free cash flow (ttm)1.34B